Loading...
Header Logo
Keywords
Last Name
Institution

Connection

Doreen Brettler to Child, Preschool

This is a "connection" page, showing publications Doreen Brettler has written about Child, Preschool.

 
Connection Strength
 
 
 
0.192
 
  1. Brettler D. A 3.5-year study of immune function in persons with hemophilia infusing recombinant factor VIII. Ann Hematol. 1994; 68 Suppl 3:S49-50.
    View in: PubMed
    Score: 0.028
  2. Brettler DB. Comments on the development of inhibitor antibodies in patients using recombinant factor VIII concentrates. Semin Hematol. 1991 Apr; 28(2 Suppl 1):45-6.
    View in: PubMed
    Score: 0.023
  3. Brettler DB, Forsberg A, Bolivar E, Brewster F, Sullivan J. Growth failure as a prognostic indicator for progression to acquired immunodeficiency syndrome in children with hemophilia. J Pediatr. 1990 Oct; 117(4):584-8.
    View in: PubMed
    Score: 0.023
  4. Brettler DB, Alter HJ, Dienstag JL, Forsberg AD, Levine PH. Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood. 1990 Jul 1; 76(1):254-6.
    View in: PubMed
    Score: 0.022
  5. Brettler DB, Forsberg AD, Levine PH, Aledort LM, Hilgartner MW, Kasper CK, Lusher JM, McMillan C, Roberts H. The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience. Arch Intern Med. 1989 Jun; 149(6):1381-5.
    View in: PubMed
    Score: 0.021
  6. Brettler DB, Brewster F, Levine PH, Forsberg A, Baker S, Sullivan JL. Immunologic aberrations, HIV seropositivity and seroconversion rates in patients with hemophilia B. Blood. 1987 Jul; 70(1):276-81.
    View in: PubMed
    Score: 0.018
  7. Brettler DB, Forsberg AD, Brewster F, Sullivan JL, Levine PH. Delayed cutaneous hypersensitivity reactions in hemophiliac subjects treated with factor concentrate. Am J Med. 1986 Oct; 81(4):607-11.
    View in: PubMed
    Score: 0.017
  8. Soucie JM, Symons J, Evatt B, Brettler D, Huszti H, Linden J. Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia. Haemophilia. 2001 Mar; 7(2):198-206.
    View in: PubMed
    Score: 0.012
  9. Shopnick RI, Brettler DB, Bolivar E. Hepatitis C virus transmission by monoclonal purified viral-attenuated factor VIII concentrate. Lancet. 1995 Sep 2; 346(8975):645.
    View in: PubMed
    Score: 0.008
  10. Luzuriaga K, Koup RA, Pikora CA, Brettler DB, Sullivan JL. Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children. J Pediatr. 1991 Aug; 119(2):230-6.
    View in: PubMed
    Score: 0.006
  11. Schwartz RS, Abildgaard CF, Aledort LM, Arkin S, Bloom AL, Brackmann HH, Brettler DB, Fukui H, Hilgartner MW, Inwood MJ, et al. Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group. N Engl J Med. 1990 Dec 27; 323(26):1800-5.
    View in: PubMed
    Score: 0.006
  12. Mannucci PM, Schimpf K, Brettler DB, Ciavarella N, Colombo M, Haschke F, Lechner K, Lusher J, Weissbach G. Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group. Ann Intern Med. 1990 Jul 1; 113(1):27-32.
    View in: PubMed
    Score: 0.006
  13. Sullivan JL, Brewster FE, Brettler DB, Forsberg AD, Cheeseman SH, Byron KS, Baker SM, Willitts DL, Lew RA, Levine PH. Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesviruses. J Pediatr. 1986 Apr; 108(4):504-10.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.